Suchergebnisse - "Pezzini, Alessandro"

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Weitere Verfasser: Wali, Nabila Stolze, Lotte J. Rinkel, Leon A. et al.

    Dateibeschreibung: application/pdf

    Relation: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Ivana Berisavac: speaker honoraria from Medtronic. Visnja Padjen: speaker honoraria from Medtronic and Boehringer Ingelheim. Ronen R. Leker: received speaker honoraria from IscemaView, Boehringer Ingelheim, Pfizer, Jansen, Biogen, Medtronic and Abott and advisory board honoraria from Jansen and Filterlex. Andrea Zini: has received funding for speaker honoraria and consulting fees from Boehringer Ingelheim, Astra Zeneca, Daiichi Sankyo, CSL Behring, for scientific advisory board from Bayer, Astra Zeneca. Mirjam R. Heldner: reports grants from Swiss National Science Foundation, SITEM Research Support Funds and Swiss Heart Foundation, not directly related to this manuscript. Christian H Nolte: has received honoraria for lectures or speaker\u2019s bureau from Alexion, AstraZeneca, BMS, Novartis and Pfizer. The other authors report nothing to disclose.; http://hdl.handle.net/10138/586118; 85203466108; 001309092000001

  12. 12

    Weitere Verfasser: SiGN FinnGen Women’s Health Initiative et al.

    Dateibeschreibung: application/pdf

    Relation: SWvdL received funding from Roche Diagnostics International Ltd for unrelated work. JdR is co-founder and director of Cyclomics, a genomics company. The authors thank the Netherlands CardioVascular Research Initiative of the Netherlands Heart Foundation (CVON 2011/B019 and CVON 2017-20: Generating the best evidence-based pharmaceutical targets for atherosclerosis [GENIUS I&II]), the ERA-CVD program \u201Cdruggable-MI-targets\u201D (grant number: 01KL1802), the Leducq Foundation \u201CPlaqOmics,\u201D (grant number: 101136962). The authors thank the participants and investigators of the FinnGen study. The authors thank the following biobanks for delivering biobank samples to FinnGen: Auria Biobank ( www.auria.fi/biopankki ), THL Biobank ( www.thl.fi/biobank ), Helsinki Biobank ( www.helsinginbiopankki.fi ), Biobank Borealis of Northern Finland ( https://www.ppshp.fi/Tutkimus-ja-opetus/Biopankki/Pages/Biobank-Borealis-briefly-in-English.aspx ), Finnish Clinical Biobank Tampere ( www.tays.fi/en-US/Research_and_development/Finnish_Clinical_Biobank_Tampere ), Biobank of Eastern Finland ( www.ita-suomenbiopankki.fi/en ), Central Finland Biobank ( www.ksshp.fi/fi-FI/Potilaalle/Biopankki ), Finnish Red Cross Blood Service Biobank ( www.veripalvelu.fi/verenluovutus/biopankkitoiminta ), Terveystalo Biobank ( www.terveystalo.com/fi/Yritystietoa/Terveystalo-Biopankki/Biopankki/ ), and Arctic Biobank ( https://www.oulu.fi/en/university/faculties-and-units/faculty-medicine/northern-finland-birth-cohorts-and-arctic-biobank ). All Finnish biobanks are members of the BBMRI.fi infrastructure ( www.bbmri.fi ). Finnish Biobank Cooperative FINBB ( https://finbb.fi/ ) is the coordinator of BBMRI-ERIC operations in Finland. The authors thank SP for supervision and mentoring during the initiation of this study.; http://hdl.handle.net/10138/586447; 85204208766; 001313825600001

  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20